144 related articles for article (PubMed ID: 27898169)
1. Cross-Sectional Analysis of Progressive Familial Intrahepatic Cholestasis in Puerto Rican Children.
Soler DM; Del Valle AI; Fernandez-Lube D; Shneider BL
P R Health Sci J; 2016 Dec; 35(4):220-223. PubMed ID: 27898169
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
[TBL] [Abstract][Full Text] [Related]
3. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
[TBL] [Abstract][Full Text] [Related]
4. Retargeting of bile salt export pump and favorable outcome in children with progressive familial intrahepatic cholestasis type 2.
Varma S; Revencu N; Stephenne X; Scheers I; Smets F; Beleza-Meireles A; Reding R; Roskams T; Sokal EM
Hepatology; 2015 Jul; 62(1):198-206. PubMed ID: 25847299
[TBL] [Abstract][Full Text] [Related]
5. Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion.
Ismail H; Kaliciński P; Markiewicz M; Jankowska I; Pawłowska J; Kluge P; Eliadou E; Kamiński A; Szymczak M; Drewniak T; Revillon Y
Pediatr Transplant; 1999 Aug; 3(3):219-24. PubMed ID: 10487283
[TBL] [Abstract][Full Text] [Related]
6. Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease.
Narkewicz MR; Smith D; Gregory C; Lear JL; Osberg I; Sokol RJ
J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):49-55. PubMed ID: 9443120
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid treatment in children with Byler disease.
Dinler G; Koçak N; Ozen H; Yüce A; Gürakan F
Pediatr Int; 1999 Dec; 41(6):662-5. PubMed ID: 10618887
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment.
Bacq Y; le Besco M; Lecuyer AI; Gendrot C; Potin J; Andres CR; Aubourg A
Dig Liver Dis; 2017 Jan; 49(1):63-69. PubMed ID: 27825922
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
Bacq Y; Sentilhes L; Reyes HB; Glantz A; Kondrackiene J; Binder T; Nicastri PL; Locatelli A; Floreani A; Hernandez I; Di Martino V
Gastroenterology; 2012 Dec; 143(6):1492-501. PubMed ID: 22892336
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
[TBL] [Abstract][Full Text] [Related]
12. Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomized study with 1-year follow-up.
van de Meeberg PC; Houwen RH; Sinaasappel M; Heijerman HG; Bijleveld CM; Vanberge-Henegouwen GP
Scand J Gastroenterol; 1997 Apr; 32(4):369-73. PubMed ID: 9140160
[TBL] [Abstract][Full Text] [Related]
13. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
[TBL] [Abstract][Full Text] [Related]
14. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
15. [Cholestatic liver diseases].
Reichel C; Meier-Abt PJ
Ther Umsch; 1997 Nov; 54(11):639-44. PubMed ID: 9454366
[TBL] [Abstract][Full Text] [Related]
16. [Long-term ursodeoxycholic acid treatment of cholestatic liver diseases in childhood--clinical and biochemical effects].
Kardorff R; Melter M; Rodeck B; Brodehl J
Klin Padiatr; 1996; 208(3):118-22. PubMed ID: 8676599
[TBL] [Abstract][Full Text] [Related]
17. [Cholestasis: therapeutic options].
Beuers U; Oswald M
Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.
Chen R; Yang FX; Tan YF; Deng M; Li H; Xu Y; Ouyang WX; Song YZ
Orphanet J Rare Dis; 2022 Dec; 17(1):445. PubMed ID: 36550572
[TBL] [Abstract][Full Text] [Related]
19. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy.
Wanty C; Joomye R; Van Hoorebeek N; Paul K; Otte JB; Reding R; Sokal EM
Acta Gastroenterol Belg; 2004; 67(4):313-9. PubMed ID: 15727074
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism in alagille syndrome and progressive familial intrahepatic cholestasis.
Socha P; Nowicka G; Jankowska I; Rujner J; Pawłowska J; Socha J
Dig Dis Sci; 2000 Apr; 45(4):675-9. PubMed ID: 10759233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
